Cite
6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib
MLA
Pankaj Gupta, et al. “6-Methoxyethylamino-Numonafide Inhibits Hepatocellular Carcinoma Xenograft Growth as a Single Agent and in Combination with Sorafenib.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 31, no. 12, Apr. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....509d77e5cb49e92a2bce33a18447a8b1&authtype=sso&custid=ns315887.
APA
Pankaj Gupta, Guohua Lou, John Norton, Nathaniel I. Shank, Shuai Tang, Michael J. Avram, Chen Wang, Sui Huang, Zhi Chen, Min Huang, Yanning Liu, Richard M. Green, Irawati Kandela, Daniel H. Appella, & Andrew P. Mazar. (2017). 6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 31(12).
Chicago
Pankaj Gupta, Guohua Lou, John Norton, Nathaniel I. Shank, Shuai Tang, Michael J. Avram, Chen Wang, et al. 2017. “6-Methoxyethylamino-Numonafide Inhibits Hepatocellular Carcinoma Xenograft Growth as a Single Agent and in Combination with Sorafenib.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 31 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....509d77e5cb49e92a2bce33a18447a8b1&authtype=sso&custid=ns315887.